Comparative efficacy of alpha-linolenic acid and gamma-linolenic acid to attenuate valproic acid-induced autism-like features
Abstract The present study was undertaken to elucidate the effect of alpha-linolenic acid (ALA, 18:3, ω-3) and gamma-linolenic acid (GLA, 18:3, ω-6) on experimental autism features induced by early prenatal exposure to valproic acid (VPA) in albino wistar pups. The pups were scrutinized on the accounts of behavioral, biochemical, and inflammatory markers, and the results suggested that the GLA can impart significant protection in comparison to ALA against VPA-induced autism features. When scrutinized histopathologically, the cerebellum of the GLA-treated animals was evident for more marked protection toward neuronal degeneration and neuronal loss in comparison to ALA. Concomitant administration of ALA and GLA with VPA demonstrated a marked cutdown in the Pgp 9.5 expression with GLA having more pronounced effect. Henceforth, it can be concluded that ALA and GLA can impart favorable protection against the VPA-induced autism-like features with GLA having pronounced effect..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:73 |
|---|---|
| Enthalten in: |
Journal of physiology and biochemistry - 73(2016), 2 vom: 22. Nov., Seite 187-198 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yadav, Sneha [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
Alpha-linolenic acid |
| Anmerkungen: |
© University of Navarra 2016 |
|---|
| doi: |
10.1007/s13105-016-0532-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2070794512 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2070794512 | ||
| 003 | DE-627 | ||
| 005 | 20230401162748.0 | ||
| 007 | tu | ||
| 008 | 200820s2016 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s13105-016-0532-2 |2 doi | |
| 035 | |a (DE-627)OLC2070794512 | ||
| 035 | |a (DE-He213)s13105-016-0532-2-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |a 540 |q VZ |
| 084 | |a 44.00$jMedizin: Allgemeines |2 bkl | ||
| 100 | 1 | |a Yadav, Sneha |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Comparative efficacy of alpha-linolenic acid and gamma-linolenic acid to attenuate valproic acid-induced autism-like features |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © University of Navarra 2016 | ||
| 520 | |a Abstract The present study was undertaken to elucidate the effect of alpha-linolenic acid (ALA, 18:3, ω-3) and gamma-linolenic acid (GLA, 18:3, ω-6) on experimental autism features induced by early prenatal exposure to valproic acid (VPA) in albino wistar pups. The pups were scrutinized on the accounts of behavioral, biochemical, and inflammatory markers, and the results suggested that the GLA can impart significant protection in comparison to ALA against VPA-induced autism features. When scrutinized histopathologically, the cerebellum of the GLA-treated animals was evident for more marked protection toward neuronal degeneration and neuronal loss in comparison to ALA. Concomitant administration of ALA and GLA with VPA demonstrated a marked cutdown in the Pgp 9.5 expression with GLA having more pronounced effect. Henceforth, it can be concluded that ALA and GLA can impart favorable protection against the VPA-induced autism-like features with GLA having pronounced effect. | ||
| 650 | 4 | |a Alpha-linolenic acid | |
| 650 | 4 | |a Autism spectrum disorder | |
| 650 | 4 | |a Gamma-linolenic acid | |
| 650 | 4 | |a Pgp 9.5 | |
| 650 | 4 | |a Polyunsaturated fatty acids | |
| 700 | 1 | |a Tiwari, Virendra |4 aut | |
| 700 | 1 | |a Singh, Manjari |4 aut | |
| 700 | 1 | |a Yadav, Rajnish K. |4 aut | |
| 700 | 1 | |a Roy, Subhadeep |4 aut | |
| 700 | 1 | |a Devi, Uma |4 aut | |
| 700 | 1 | |a Gautam, Swetlana |4 aut | |
| 700 | 1 | |a Rawat, Jitendra Kumar |4 aut | |
| 700 | 1 | |a Ansari, Mohd. Nazam |4 aut | |
| 700 | 1 | |a Saeedan, Abdulaziz Sa |4 aut | |
| 700 | 1 | |a Prakash, Anand |4 aut | |
| 700 | 1 | |a Saraf, Shubhini A. |4 aut | |
| 700 | 1 | |a Kaithwas, Gaurav |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of physiology and biochemistry |d Springer Netherlands, 1996 |g 73(2016), 2 vom: 22. Nov., Seite 187-198 |w (DE-627)214065359 |w (DE-600)1325104-1 |x 1138-7548 |7 nnns |
| 773 | 1 | 8 | |g volume:73 |g year:2016 |g number:2 |g day:22 |g month:11 |g pages:187-198 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s13105-016-0532-2 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.00$jMedizin: Allgemeines |q VZ |0 106409646 |0 (DE-625)106409646 |
| 951 | |a AR | ||
| 952 | |d 73 |j 2016 |e 2 |b 22 |c 11 |h 187-198 | ||